Huang Chuan, Xu Ying Chun, Kuang Li Hua, Lan Qiong Yu, Hu Jing, Zhu Wenbing, Fan Liqing, Li Qing
Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
The Reproductive & Genetic Hospital of CITIC-XIANGYA, Changsha, China.
Front Reprod Health. 2022 Jan 31;4:801378. doi: 10.3389/frph.2022.801378. eCollection 2022.
The purpose of this study was to help to promote a better understanding of the male fertility preservation status in China.
In this cross-sectional survey, 1,912 healthcare providers and oncologists were surveyed anonymously using 16 questions carried out at community oncology practices in China from September 2018 to April 2021. 16 questions were designed to evaluate their knowledge on male fertility preservation in cancer patients, assess the factors they considered when deciding whether to discuss male fertility preservation with their patients.
Among the 1,912 healthcare providers (42.2% male), 1,713 (89.6%) considered that patients with cancer should be recommended for fertility preservation. 1,264 (66.1%) respondents were aware of male fertility preservation, but only 248 (13.0%) respondents knew the correct institutions. Whether a healthcare provide recommended fertility preservation to their patients depended on the provider's educational background, professional qualifications, hospital grade, area, department, and age. Among the healthcare providers, the three main factors for not recommending fertility preservation for patients with cancer were lack of suitability of the patient for fertility (28.2%), lack of knowledge of fertility preservation (28.6%), and lack of knowledge concerning the institutes that provide fertility preservation (25.4%).
Despite this, healthcare providers and oncologists in China showed a positive attitude toward fertility preservation in patients with cancer. Hence, the education of physicians should include fertility preservation, with the aim of increasing their knowledge and awareness. There should be more collaboration between oncologists and reproductive medicine specialists.
本研究旨在促进对中国男性生育力保存现状的更好理解。
在这项横断面调查中，于2018年9月至2021年4月期间，在中国社区肿瘤医疗实践中，使用16个问题对1912名医疗服务提供者和肿瘤学家进行了匿名调查。这16个问题旨在评估他们对癌症患者男性生育力保存的知识，以及评估他们在决定是否与患者讨论男性生育力保存时所考虑的因素。
在1912名医疗服务提供者中（42.2%为男性），1713人（89.6%）认为癌症患者应被推荐进行生育力保存。1264名（66.1%）受访者知晓男性生育力保存，但只有248名（13.0%）受访者知道正确的机构。医疗服务提供者是否向患者推荐生育力保存取决于提供者的教育背景、专业资格、医院等级、地区、科室和年龄。在医疗服务提供者中，不向癌症患者推荐生育力保存的三个主要因素是患者不适合生育（28.2%）、缺乏生育力保存知识（28.6%）以及缺乏关于提供生育力保存机构的知识（25.4%）。
尽管如此，中国的医疗服务提供者和肿瘤学家对癌症患者的生育力保存表现出积极态度。因此，医生教育应包括生育力保存内容，以增加他们的知识和意识。肿瘤学家和生殖医学专家之间应加强合作。
